Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tafoxiparin adjunct to oxytocin for slow labor progression
2016-002118-40Phase 2Completed
- Sponsor
- Dilafor AB
- Start
- Jul 2016
- Modality
- Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in labor dystocia and Arrest of labor comparing Tafoxiparin + oxytocin with Placebo + oxytocin (2 arms). Primary endpoint: Time from start of infusion of tafoxiparin/placebo until vaginal partus. Started Jul 2016; status: completed.
02
Drugs
tafoxiparin
03
Conditions
labor dystociaArrest of labor
Beyond the preview
Go deeper on 2016-002118-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002118-40.